Reid, Steven, Chalder, Trudie, Cleare, Anthony et al. · BMJ clinical evidence · 2011
This review looked at treatments for ME/CFS by examining 46 high-quality studies published up to March 2010. The researchers assessed which treatments—including antidepressants, exercise therapy, cognitive behavioral therapy, and supplements—actually work and are safe. The review shows that ME/CFS affects less than 3% of people, with more women than men experiencing the condition.
This systematic review provides a comprehensive evidence base for both patients and clinicians evaluating treatment options for ME/CFS, a condition with significant disability burden and variable population prevalence depending on diagnostic criteria. By synthesizing multiple intervention categories with quality-of-evidence ratings, it helps identify which treatments have stronger support and highlights areas where evidence remains weak.
This review does not establish causation for any intervention—it summarizes existing evidence without conducting new trials. The findings are limited by the quality and quantity of underlying studies for each intervention, and the varying definitions of ME/CFS used across included studies may limit generalizability. Individual treatment responses may differ significantly from population-level findings.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →